Search results
Sotrovimab is indicated for children ≥ 12 years of age and weighing ≥ 40 kg with laboratory evidence of SARS-CoV-2 infection, mild to moderate COVID-19, within 10 days of symptom onset, and at high risk for progressing to severe COVID-19 and/or hospitalization [76••, 77••].
19 paź 2021 · Almost any rash in a child should raise suspicion of COVID-19, especially acral rashes similar to pernio. Rashes may be subtle, mild, and morphologies may vary. Distributions may differ in children compared with adults.
4 kwi 2021 · In Part 1, we discuss one of the first and most widespread cutaneous manifestations of COVID‐19, chilblain‐like lesions, and in Part 2 we expanded to other manifestations, including erythema multiforme, urticaria and Kawasaki disease‐like inflammatory multisystemic syndrome.
25 wrz 2024 · Rashes linked to the COVID virus can appear in many ways, but this toe rash—dubbed "COVID toes"—is one of the most common. Learn more about what to look for in a COVID-19 rash, potential complications, and how to treat COVID-19 rashes in kids.
10 mar 2022 · Chilblains constitute the most common cutaneous manifestation of pediatric coronavirus disease (COVID-19). Other commonly reported manifestations include maculopapular rash, urticaria, erythema multiforme, and papulovesicular eruptions.
In this review, we summarize the current knowledge on the cutaneous manifestations of COVID-19 in children after thorough and critical review of articles published in the literature and from the personal experience of a large panel of paediatric dermatologists in Europe.
18 lut 2022 · Papulosquamous rashes in COVID-19 consist of scaly macules and papules that may be localized or confluent. Characteristic papules are perifollicular and itchy. Some patients develop purpura and pseudo-vesicles.
